A P2RX1 overexpression model was established in the SUP-B15 Ph+ ALL cell line, and a series of functional experiments were conducted to assess its impact on tyrosine kinase inhibitor-induced apoptosis and proliferation capacity. The gene discussed is P2RX1; the disease is acute lymphoblastic leukemia.